HomeANR • ASX
add
Anatara Lifesciences Ltd
Previous close
$0.010
Year range
$0.0040 - $0.020
Market cap
3.16M AUD
Avg Volume
432.65K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 88.78K | -66.07% |
Operating expense | 263.18K | -32.16% |
Net income | -257.49K | 55.65% |
Net profit margin | -290.02 | -30.70% |
Earnings per share | — | — |
EBITDA | -256.39K | 55.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.09M | -1.50% |
Total assets | 1.33M | -24.67% |
Total liabilities | 195.92K | -51.50% |
Total equity | 1.13M | — |
Shares outstanding | 313.59M | — |
Price to book | ∞ | — |
Return on assets | -48.34% | — |
Return on capital | -56.72% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -257.49K | 55.65% |
Cash from operations | 141.03K | 131.36% |
Cash from investing | — | — |
Cash from financing | 350.89K | -31.14% |
Net change in cash | 491.91K | 1,313.26% |
Free cash flow | -161.19K | 49.94% |
About
Founded
2010
Website
